Table 4.
Logistic regression model for predicting EBV-IM using hepatobiliary biomarkers (model 3).
| Odds ratio [95% CI] | p-value | |
|---|---|---|
| Age | ||
| <31 years | 1 | N/A |
| 31–40 years | 0.24 [0.049–1.24] | 0.082 |
| >40 years | 0.029 [0.0036–0.24] | 0.001 |
| Cervical lymphadenopathy | 7.13 [1.89–26.95] | 0.004 |
| Tonsillar white coat | 12.20 [1.67–89.23] | 0.014 |
| Hepatosplenomegaly | 2.51 [0.70–9.03] | 0.16 |
| Leukocytosis | 3.01 [0.64–14.11] | 0.16 |
| Atypical lymphocytes | ||
| <11% | 1 | N/A |
| 11–30% | 11.51 [1.03–129.01] | 0.048 |
| >30% | 4.53 [0.67–30.57] | 0.12 |
| ALT | ||
| <41 IU/L | 1 | N/A |
| 41–200 IU/L | 0.33 [0.043–2.57] | 0.29 |
| >200 IU/L | 0.25 [0.013–4.95] | 0.37 |
| LDH | ||
| <251 IU/L | 1 | N/A |
| 251–500 IU/L | 17.65 [1.08–289.53] | 0.044 |
| >500 IU/L | 13.01 [0.62–274.83] | 0.099 |
| ALP | ||
| <351 IU/L | 1 | N/A |
| 351–500 IU/L | 0.50 [0.062–4.06] | 0.52 |
| >500 IU/L | 3.23 [0.30–34.3] | 0.33 |
| GGT | ||
| <51 IU/L | 1 | N/A |
| 51–300 IU/L | 11.11 [1.46–71.48] | 0.02 |
| >300 IU/L | 11.82 [0.41–337.04] | 0.15 |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; CI, confidence interval; CRP, C-reactive protein; EBV-IM, infectious mononucleosis caused by the Epstein-Barr virus; GGT, gamma-glutamyl transferase; LDH, lactate dehydrogenase; N/A, not applicable.